Cargando…
A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients
Purpose: High-dose heparin has been suggested to reduce consumption coagulopathy. Materials and Methods: In a randomized, blinded, prospective trial of patients undergoing elective, complex cardiac surgery with cardiopulmonary bypass, patients were randomized to one of three groups: 1) high-dose hep...
Autores principales: | Nuttall, Gregory A., Smith, Mark M., Smith, Bradford B., Christensen, Jon M., Santrach, Paula J., Schaff, Hartzell V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209891/ https://www.ncbi.nlm.nih.gov/pubmed/34937821 http://dx.doi.org/10.5761/atcs.oa.21-00222 |
Ejemplares similares
-
Formation of intracardiac thrombus during cardiopulmonary bypass despite full heparinization and adequate activated clotting time -A case report-
por: Kim, So Yeon, et al.
Publicado: (2012) -
Heparin-coated vs. Non-coated Cardiopulmonary Bypass Circuits: Comparing Immediate Results with Different Target Activated Clotting Time
por: Hanedan, Muhammet Onur, et al.
Publicado: (2020) -
An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008) -
Use of activated clotting time to monitor anticoagulation in patients receiving unfractionated heparin on renal replacement therapy
por: Bidwai, A, et al.
Publicado: (2011) -
Comparison of digoxin concentration in plastic serum tubes with clot activator and heparinized plasma tubes
por: Dukić, Lora, et al.
Publicado: (2014)